Catalyst Wire Dossier Catalyst Wire Dossier

Epoprostenol for Injection (EFI/ACT-385781A)

epoprostenol · Actelion
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Epoprostenol for Injection (EFI/ACT-385781A), covering 2015-01-13 to 2015-01-13. Get the full timeline:

Most recent: Clinical Trial Update: Epoprostenol for Injection (EFI/ACT-385781A) - Pulmonary Arterial Hypertension [Phase 3]

See pricing